Evidence from human and mouse studies demonstrated that IFN-α can enhance HLA class I expression in islets, promoting β cell antigen presentation and CD8+ T cell–mediated cytotoxicity in T1D (29, 30). This evidence concerns the gene CD8A and type 1 diabetes mellitus.